165 related articles for article (PubMed ID: 29188456)
1. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.
Eto K; Hiki N; Kumagai K; Shoji Y; Tsuda Y; Kano Y; Yasufuku I; Okumura Y; Tsujiura M; Ida S; Nunobe S; Ohashi M; Sano T; Yamaguchi T
Gastric Cancer; 2018 Jul; 21(4):703-709. PubMed ID: 29188456
[TBL] [Abstract][Full Text] [Related]
2. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
3. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Prolonged Inflammatory Response as a Poor Prognostic Factor After Curative Resection for Gastric Cancer.
Okumura Y; Hiki N; Kumagai K; Ida S; Nunobe S; Ohashi M; Sano T
World J Surg; 2017 Oct; 41(10):2611-2618. PubMed ID: 28451762
[TBL] [Abstract][Full Text] [Related]
5. Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?
Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Gastric Cancer; 2019 Nov; 22(6):1274-1284. PubMed ID: 30945120
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative blood loss as an independent prognostic factor for curative resection after neoadjuvant chemotherapy for gastric cancer: a single-center retrospective cohort study.
Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Surg Today; 2021 Feb; 51(2):293-302. PubMed ID: 32839832
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.
Feng D; Leong M; Li T; Chen L; Li T
World J Surg Oncol; 2015 Jan; 13():11. PubMed ID: 25634099
[TBL] [Abstract][Full Text] [Related]
8. Effect of neoadjuvant treatment combined with radical gastrectomy on postoperative complications and prognosis of gastric cancer patients.
Zhou Y; Tian Z; Zeng J; Zhou W; Wu K; Shen W
Scand J Gastroenterol; 2021 Nov; 56(11):1343-1348. PubMed ID: 34415219
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
10. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
[TBL] [Abstract][Full Text] [Related]
11. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
13. Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation?
Saito T; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
J Surg Oncol; 2015 Dec; 112(8):894-9. PubMed ID: 26458724
[TBL] [Abstract][Full Text] [Related]
14. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y;
J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.
Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
J Cancer Res Clin Oncol; 2006 Dec; 132(12):781-5. PubMed ID: 16804723
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of complications after curative surgery for gastric cancer.
Kubota T; Hiki N; Sano T; Nomura S; Nunobe S; Kumagai K; Aikou S; Watanabe R; Kosuga T; Yamaguchi T
Ann Surg Oncol; 2014 Mar; 21(3):891-8. PubMed ID: 24254205
[TBL] [Abstract][Full Text] [Related]
18. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.
Li Z; Bai B; Zhao Y; Yu D; Lian B; Liu Y; Zhao Q
Int J Surg; 2018 Jun; 54(Pt A):62-69. PubMed ID: 29698790
[TBL] [Abstract][Full Text] [Related]
19. Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.
Mohri Y; Tanaka K; Toiyama Y; Ohi M; Yasuda H; Inoue Y; Kusunoki M
Medicine (Baltimore); 2016 Mar; 95(11):e3125. PubMed ID: 26986164
[TBL] [Abstract][Full Text] [Related]
20. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
